OFFICIAL PUBLICATION OF

by its subsidiary APPco

Stakeholders reject Interim Report options

Megan Haggan 04/08/2017

Members of the Medicines Partnership of Australia have banded together to raise concerns about the future stability of pharmacy The stakeholders, which include the Guild, PSA, ASMI, Generic and Biosimilar Medicines Association, Medicines Australia and CSO wholesalers, formally responded to the King Review interim report by highlighting their objections to aspects of the report. The

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Eli Lilly clarifies Mounjaro availability

Lilly doesn't have needle production facilities. That is not their fault, you can't expect them to build a needle factory…

Tony Chiang

Funding secured for non-8CPA programs

Well done! Good to see pharmacy profession progressions

Wilson Tan

Funding secured for non-8CPA programs

Medschecks are part of the 8CPA. Have already had secured funding with indexation despite no evidence of value.

Big Pharma

Stakeholders reject Interim Report options

Previous Teen suicide drama sparks internet searches

Next API sees decline in consumer spending

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Teen suicide drama sparks internet searches

Next API sees decline in consumer spending

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.